TW FB IG

Eng

No products in the cart.

No products in the cart.

Home / Human Rights / The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance

February 12, 2023 by Lezzie 0 comments Human Rights

Proceedings of the National Academy of Sciences, Volume 120, Issue 7, February 2023.
Read More

PREVIntermountain Delta Hospital Receives Human Experience Guardian of Excellence Award
NEXTWFP distributes emergency food assistance in Kherson
img